Eugene Bauer - 08 Dec 2025 Form 4 Insider Report for Evommune, Inc.

Reporting relationship: Chief Medical Officer, Director
Issuer ticker: EVMN on NYSE
Reported as of: 08 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Dec 2025, 16:06:11 UTC
Prior SEC filing: 12 Nov 2025
Next SEC filing: 11 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Gregory S. Moss, Attorney-in-Fact

Key filing fact

Eugene Bauer filed Form 4 for Evommune, Inc. on 19 Dec 2025.

Key facts

This page summarizes Eugene Bauer's Form 4 filing for Evommune, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 19 Dec 2025, 16:06.

Change

Previous filing in this sequence was filed on 12 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001678620 Primary reporting owner

Bauer Eugene

Relationship: Chief Medical Officer, Director
Address: C/O EVOMMUNE, INC., 1841 PAGE MILL ROAD, SUITE 100, PALO ALTO
Signature: /s/ Gregory S. Moss, Attorney-in-Fact
Signature date: 19 Dec 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EVMN transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +100,000
Change %
Price: $0.000000
Shares after: 100,000
Date: 08 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $18.44
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

One fourth (1/4) of the shares subject to the option award shall vest on December 8, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.